Koshinski Asset Management, Inc. Zoetis Inc. Transaction History

Koshinski Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$165.67 - $199.94 $65,605 - $79,176	-396 Reduced 24.49%	1,221 $206,000
Q4 2023 Jan 29, 2024	BUY	$151.44 - $200.09 $244,878 - $323,545	1,617 New	1,617 $319,000
Q2 2022 Jul 12, 2022	SELL	$155.97 - $200.09 $142,400 - $182,682	-913 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$181.39 - $234.03 $1,088 - $1,404	6 Added 0.66%	913 $172 Million
Q3 2021 Oct 12, 2021	BUY	$189.29 - $209.69 $171,686 - $190,188	907 New	907 $176,000
Q1 2021 May 06, 2021	SELL	$144.0 - $169.39 $205,344 - $241,550	-1,426 Closed	0 $0
Q4 2020 Mar 30, 2021	BUY	$157.07 - $174.35 $223,981 - $248,623	1,426 New	1,426 $205,000
Q4 2018 Feb 08, 2019	SELL	$79.28 - $95.27 $189,796 - $228,076	-2,394 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$83.5 - $93.23 $199,899 - $223,192	2,394 New	2,394 $219,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.